Plerixafor as a salvage mobilization strategy for haploidentical peripheral blood allogeneic stem cell transplantation

By  

Clinical Case Reports, Vol. 3, Iss. 9, 2015-09 ,pp. : 728-730

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Utility of Tetramer-Based Immune Monitoring in Allogeneic Stem Cell Transplantation

By Gratama J.W.  

BioDrugs, Vol. 17, Iss. 5, 2003-01 ,pp. : 325-338

Adis International

Access to resources Recommend Favorite

Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report

By  

Clinical Case Reports, Vol. 3, Iss. 7, 2015-07 ,pp. : 650-655

John Wiley & Sons Inc

Access to resources Recommend Favorite

Induction with azacytidine followed by allogeneic hematopoietic stem cell transplantation in a Jehovah's Witness with acute monocytic leukemia

By  

Clinical Case Reports, Vol. 3, Iss. 5, 2015-05 ,pp. : 287-290

John Wiley & Sons Inc

Access to resources Recommend Favorite

A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome

By Fung H.C.   Stein A.   Slovak M.L.   O'Donnell M.R.   Snyder D.S.   Cohen S.   Smith D.   Krishnan A.   Spielberger R.   Bhatia R.   Bhatia S.   Falk P.   Molina A.   Nademanee A.   Parker P.   Rodriguez R.   Rosenthal J.   Sweetman R.   Kogut N.   Sahebi F.   Popplewell L.   Vora N.   Somlo G.   Margolin K.   Chow W.   Smith E.   Forman S.J.  

Biology of Blood and Marrow Transplantation, Vol. 9, Iss. 12, 2003-12 ,pp. : 766-771

Elsevier

Access to resources Recommend Favorite